Biotech · Private company
Blue Lake Biotechnology Inc.
Track this companyFree. Adds Blue Lake Biotechnology Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- PIV5-vectored RSV Vaccine (BLB-201) High DosePhase 2 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- PIV5-vectored RSV Vaccine (BLB-201) Low DosePhase 2 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- CPI-RSV-F Vaccine (BLB-201)Phase 1 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of BLB-201 RSV Vaccine in Infants and ChildrenPHASE1_PHASE2 · RECRUITING · started Mar 9, 2023ClinicalTrials.gov NCT05655182 · fetched Nov 12, 2026
- Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older AdultsPHASE1 · COMPLETED · started Jul 20, 2022ClinicalTrials.gov NCT05281263 · fetched Nov 12, 2026